Take off with Intelligent Bio Solutions Inc. (INBS): Get ready for trading

Intelligent Bio Solutions Inc. (NASDAQ: INBS) stock jumped 293.13% on Monday to $1.03 against a previous-day closing price of $0.26. With 146.28 million shares changed hands, the volume of the stock remained heavier than its average volume of 54420.0 shares. During the session, the Diagnostics & Research company that operates in wider Healthcare sector, reached to the highest price of $1.6000 whereas the lowest price it dropped to was $0.9200. The 52-week range on INBS shows that it touched its highest point at $1.54 and its lowest point at $0.17 during that stretch. It currently has a 1-year price target of $1.60.

Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.

Sponsored

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of INBS was up-trending over the past week, with a rise of 268.25%, but this was up by 261.66% over a month. Three-month performance surged to 118.22% while six-month performance rose 41.37%. The stock lost -33.55% in the past year, while it has gained 415.26% so far this year. A look at the trailing 12-month EPS for INBS yields -0.54 with Next year EPS estimates of -0.15.

Float and Shares Shorts:

At present, 14.89 million INBS shares are outstanding with a float of 14.74 million shares on hand for trading. On Oct 13, 2022, short shares totaled 0.15 million, which was 1.02% higher than short shares on Sep 14, 2022. In addition to Dr. Stephen Constantine Boyages M.D., MBBS, Ph.D. as the firm’s Interim CEO & Chairman, Mr. Spiro Kevin Sakiris B.Bus, C.A., CA, Dip Law serves as its Chief Financial Officer.


Institutional Ownership:

Through their ownership of 2.79% of INBS’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 9.44% of INBS, in contrast to 1.15% held by mutual funds. Shares owned by individuals account for 0.70%. As the largest shareholder in INBS with 0.63% of the stake, Geode Capital Management LLC holds 115,825 shares worth 115,825. A second-largest stockholder of INBS, Renaissance Technologies LLC, holds 107,000 shares, controlling over 0.58% of the firm’s shares. Citadel Securities LLC is the third largest shareholder in INBS, holding 34,574 shares or 0.19% stake. With a 0.61% stake in INBS, the Fidelity Extended Market Index Fu is the largest stakeholder. A total of 111,626 shares are owned by the mutual fund manager. The Vanguard Extended Market Index Fu, which owns about 0.07% of INBS stock, is the second-largest Mutual Fund holder. It holds 11,850 shares valued at 2370.0. Vanguard Invt. Fds. ICVC – US Equ holds 0.03% of the stake in INBS, owning 5,066 shares worth 1013.0.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for INBS since 1 analysts follow the stock currently. There are 1 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With INBS analysts setting a high price target of $1.60 and a low target of $1.60, the average target price over the next 12 months is $1.60. Based on these targets, INBS could surge 55.34% to reach the target high and rise by 55.34% to reach the target low. Reaching the average price target will result in a growth of 55.34% from current levels.


EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. INBS will report FY 2023 earnings on 08/31/2023. Analysts have provided yearly estimates in a range of -$0.33 being high and -$0.33 being low. For INBS, this leads to a yearly average estimate of -$0.33. The surprise factor in the prior quarter was -$0.08. Based on analyst estimates, the high estimate for the next quarter is -$0.11 and the low estimate is -$0.11. The average estimate for the next quarter is thus -$0.11.

Summary of Insider Activity:

Insiders traded INBS stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has increased to 9 while that of sell transactions has risen to 11 over the past year. The total number of shares bought during that period was 310,970 while 1,100,000 shares were sold.

Leave a Comment

Your email address will not be published. Required fields are marked *